Aarti Pharmalabs Ltd.

Pursuant to Company’s Code Prohibition of Insider Trading framed pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendments thereunder, Aarti Pharmalabs has informed that the trading window for dealing in the securities of the Company will remain closed from Thursday, January 01, 2026 till 48 hours after the declaration of Financial Results of the Company for the quarter ending December 31, 2025. The same has also been intimated to all the Designated Persons/Connected Persons of the Company. The date of the Board Meeting in which the said results will be considered for approval, will be informed in due course.

The above information is a part of company’s filings submitted to BSE.